Pravastatin vs Tofacitinib
Pravastatin vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Pravastatin and Tofacitinib.
Mechanism of Action
Pravastatin: Competitive inhibitor of HMG-CoA reductase.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Pravastatin — 1.8 hours; Tofacitinib — 3.2 hours.
Chemical Properties
Molecular Formula: Pravastatin — C23H36O7; Tofacitinib — C16H20N6O.
Molecular Weight: Pravastatin — 424.5280 g/mol; Tofacitinib — 312.3700 g/mol.
Type: Pravastatin — Small molecule; Tofacitinib — Small molecule.